World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
SWTXSpringWorks Therapeutics | $3.37bn | n/a | n/a |
SYNGENESyngene International | IN₹280.34bn | 54.08 | 0.18% |
CRNXCrinetics Pharmaceuticals | $3.28bn | n/a | n/a |
FTREFortrea Holdings | $3.25bn | 260.42 | n/a |
IOVAIovance Biotherapeutics | $3.25bn | n/a | n/a |
TLXTelix Pharmaceuticals | AU$4.83bn | 841.9 | n/a |
XENEXenon Pharmaceuticals | $3.06bn | n/a | n/a |
FOLDAmicus Therapeutics | $3.04bn | n/a | n/a |
1548Genscript Biotech | HK$23.41bn | n/a | n/a |
IDYAIdeaya Biosciences | $2.99bn | n/a | n/a |
6446PHARMAESSENTIA | TWD94.76bn | n/a | n/a |
AZTAAzenta | $2.91bn | n/a | n/a |
KDNYChinook Therapeutics | $2.90bn | n/a | n/a |
ACLXArcellx | $2.77bn | n/a | n/a |
ACADAcadia Pharmaceuticals | $2.75bn | n/a | n/a |
MORMorphosys AG | €2.56bn | n/a | n/a |
ARWRArrowhead Pharmaceuticals | $2.74bn | n/a | n/a |
CGONCG Oncology | $2.73bn | n/a | n/a |
MLTXMoonLake Immunotherapeutics | $2.71bn | n/a | n/a |
SMMTSummit Therapeutics | $2.71bn | n/a | n/a |